Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mast Cell Activation Disorders × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 237 Breast Neoplasms 233 Carcinoma, Non-Small-Cell Lung 196 Prostatic Neoplasms 156 Lung Neoplasms 139 Colorectal Neoplasms 136 Neoplasm Metastasis 122 Leukemia, Myeloid, Acute 107 Ovarian Neoplasms 98 Multiple Myeloma 94 Pancreatic Neoplasms 83 Melanoma 74 Stomach Neoplasms 69 Endometrial Neoplasms 69 Squamous Cell Carcinoma of Head and Neck 67 Recurrence 67 Triple Negative Breast Neoplasms 61 Precursor Cell Lymphoblastic Leukemia-Lymphoma 59 Carcinoma, Hepatocellular 58 Lymphoma 57 Uterine Cervical Neoplasms 53 Urinary Bladder Neoplasms 53 Glioblastoma 51 Brain Neoplasms 50 Carcinoma, Renal Cell 48 Lymphoma, Large B-Cell, Diffuse 46 Sarcoma 44 Lymphoma, Non-Hodgkin 44 Myelodysplastic Syndromes 43 Hematologic Neoplasms 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06186856 2026-03-05

DATAMAST

Imagine Institute

13,000 enrolled

Mast Cell Activation Disorders, Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡